Vimarsana
Biggest News Aggregation in the World

Page 8 - Tom Narayan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tom Narayan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tom Narayan Today - Breaking & Trending Today

Tesla bear says Elon Musk's EV maker will 'go bust,' stock worth $14 - Vimarsana News

Tesla bear says Elon Musk's EV maker will 'go bust,' stock worth $14

Tesla is facing a price war, intense competition from Chinese players and weakening demand for its electric cars.

Source: cnbc.com
TESLA : RBC keeps its Buy rating -April 02, 2024 at 11:08 am EDT - Vimarsana News

TESLA : RBC keeps its Buy rating -April 02, 2024 at 11:08 am EDT

Tom Narayan from RBC retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at USD 298.

Related Topics:
Tom Narayan
Tesla dives into advertising after years of resistance - Vimarsana News

Tesla dives into advertising after years of resistance

Tesla has for most of its history been firmly averse to advertising. In recent months, however, the electric-vehicle maker has hiked spending on a variety of paid media platforms—and not just the one owned by its boss, Elon Musk.

Tesla Q1 Deliveries Preview: Analysts Cut Targets, 'Nightmare Quarter For Tesla' - Tesla (NASDAQ:TSLA) - Vimarsana News

Tesla Q1 Deliveries Preview: Analysts Cut Targets, 'Nightmare Quarter For Tesla' - Tesla (NASDAQ:TSLA)

Analysts are cutting their estimates for Tesla's first quarter deliveries. A look at key estimates and what it means.

Tesla Is Navigating Free FSD Trials, Gigafactory Challenges, and Governance Hurdles: Analyst - Tesla (NASDAQ:TSLA) - Vimarsana News

Tesla Is Navigating Free FSD Trials, Gigafactory Challenges, and Governance Hurdles: Analyst - Tesla (NASDAQ:TSLA)

RBC analyst maintains Outperform rating on TSLA with $298 price target. Q4 saw demand pull-forward and disruptions in Berlin, FSD free trials expected to drive Q2 volumes. HSBC analyst retains Reduced rating and $143 target, citing price cuts and concerns over pre-revenue opportunities.